Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
August 16, 2017OncotargetOpen Access

The prognostic significance of combined androgen receptor, E-Cadherin, Ki67 and CK5/6 expression in patients with triple negative breast cancer

View Full Paper
Ask AI
Bookmark
Share

Authors

BABárbara AdamoNorthwestern UniversityGRGiuseppina Rosaria Rita RicciardiAzienda Ospedaliera Ospedali Riuniti Papardo PiemonteAIAntonio IeniUniversity of Messina

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Adamo et al. (2017) studied this question.

synapsesocial.com/papers/6ab4cb61de45f22186b0b13bhttps://doi.org/10.18632/oncotarget.20293
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1E‐cadherin expression in invasive non‐lobular carcinoma of the breast and its prognostic significance2005 · 176 citations
  2. 2Keratins and disease at a glance2012 · 91 citations
  3. 3Expression and Clinical Significance of Androgen Receptor in Triple-Negative Breast Cancer2017 · 80 citations
  4. 4Androgen receptor expression predicts different clinical outcomes for breast cancer patients stratified by hormone receptor status2016 · 65 citations
  5. 5Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies2011 · 5,700 citations